Published in J Hepatol on July 24, 2007
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology (2008) 5.45
Acute selenium toxicity associated with a dietary supplement. Arch Intern Med (2010) 1.78
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol (2014) 1.70
Acute liver injury induced by weight-loss herbal supplements. World J Hepatol (2010) 1.57
Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem (2009) 1.50
Slimming at all costs: Herbalife-induced liver injury. J Hepatol (2007) 1.09
Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol (2015) 1.04
Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol (2014) 1.04
Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol (2013) 0.99
Samsoeum, a traditional herbal medicine, elicits apoptotic and autophagic cell death by inhibiting Akt/mTOR and activating the JNK pathway in cancer cells. BMC Complement Altern Med (2013) 0.92
Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol (2013) 0.87
Aloe-induced toxic hepatitis. J Korean Med Sci (2010) 0.87
Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. Biomed Res Int (2013) 0.83
Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests. World J Hepatol (2013) 0.82
Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. Int J Mol Sci (2016) 0.82
Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. Int J Mol Sci (2016) 0.82
Herbal medicine-related hepatotoxicity. World J Hepatol (2015) 0.80
Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ - Hawaii, 2013. Drug Test Anal (2015) 0.79
Novel in vitro and mathematical models for the prediction of chemical toxicity. Toxicol Res (Camb) (2012) 0.78
Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China. Gut Liver (2015) 0.78
Spanish reports of hepatotoxicity associated with Herbalife products. J Hepatol (2008) 0.78
Severe drug induced acute hepatitis associated with use of St John's wort (Hypericum perforatum) during treatment with pegylated interferon α. BMJ Case Rep (2009) 0.77
Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation. Biomed Res Int (2015) 0.76
Drug-induced Liver Injury. US Gastroenterol Hepatol Rev (2010) 0.76
Weight Loss Supplements: Boon or Bane? Malays J Med Sci (2017) 0.75
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res (2017) 0.75
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med (2007) 3.72
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology (2008) 2.80
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection. Clin Pharmacol Ther (2003) 2.05
BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology (2004) 1.88
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology (2002) 1.85
Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis (2007) 1.80
Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the rat. J Hepatol (2004) 1.69
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol (2006) 1.67
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol (2013) 1.58
Fatal liver failure with atorvastatin. J Hepatol (2003) 1.49
Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis. Ann Surg (2007) 1.48
Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol (2010) 1.46
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med (2009) 1.42
Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg (2004) 1.39
Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion (2003) 1.33
Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. J Hepatol (2006) 1.27
Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc (2012) 1.24
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clin Sci (Lond) (2009) 1.22
Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer. Eur J Cancer (2010) 1.21
Adhesion molecules in human pancreatic cancer. J Surg Oncol (2002) 1.19
Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer (2007) 1.18
Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass. J Bone Miner Res (2007) 1.17
Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene (2002) 1.15
Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J Surg (2002) 1.15
Adverse drug events caused by medication errors in medical inpatients. Swiss Med Wkly (2004) 1.14
Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol (2005) 1.12
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma. Histopathology (2012) 1.11
Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. Gastroenterology (2003) 1.11
Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (2004) 1.09
Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. Eur J Cancer (2012) 1.06
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term. J Hepatol (2005) 1.02
A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. Haematologica (2007) 1.01
Atypical molecular background of glioblastoma and meningioma developed in a patient with Li-Fraumeni syndrome. J Neurooncol (2005) 1.00
Herpes simplex virus hepatitis 4 years after liver transplantation. J Gastroenterol (2003) 0.98
Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma. Cancer (2002) 0.96
Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Invest (2003) 0.96
Microcystic serous cystadenoma of the pancreas: a report of two cases with one of diffuse presentation. Pancreatology (2006) 0.96
Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis. Mol Cell Endocrinol (2003) 0.95
Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Liver Int (2007) 0.94
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C. Liver Int (2007) 0.92
Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin. Exp Biol Med (Maywood) (2006) 0.92
Phosphatidylserine receptor in chronic pancreatitis: evidence for a macrophage independent role. Ann Surg (2005) 0.91
Effects of immunosuppressant FTY720 on renal and hepatic hemodynamics in the rat. Transplantation (2002) 0.91
Human macrophage metalloelastase worsens the prognosis of pancreatic cancer. Ann Surg (2002) 0.90
Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis. Liver Int (2009) 0.90
Adult-type hepatocellular carcinoma in the center of a fibrolamellar hepatocellular carcinoma. Hum Pathol (2002) 0.89
Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas. Am J Clin Pathol (2008) 0.88
Myoid hamartoma of the liver--a novel variant of hamartoma developing in the hilar region and imitating a malignant liver tumor. Med Sci Monit (2004) 0.88
Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts. Clin Pharmacol Ther (2003) 0.88
Down-regulation of DOC-2 in colorectal cancer points to its role as a tumor suppressor in this malignancy. Dis Colon Rectum (2002) 0.87
Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers. Clin Pharmacokinet (2002) 0.87
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Pathology (2010) 0.87
Emergency pancreatoduodenectomy in nontrauma patients. Pancreas (2002) 0.86
Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. J Hepatol (2006) 0.86
Current issues and controversies in the classification of pediatric hepatocellular tumors. Pediatr Blood Cancer (2012) 0.86
Role of Hepatic Stellate Cells in the Early Phase of Liver Regeneration in Rat: Formation of Tight Adhesion to Parenchymal Cells. Comp Hepatol (2004) 0.85
HGF/c-Met related activation of β-catenin in hepatoblastoma. J Exp Clin Cancer Res (2011) 0.84
Acute hepatitis associated with montelukast. J Hepatol (2003) 0.84
Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol (2002) 0.84
Epstein-Barr virus-associated lymphoepithelial carcinoma in the pancreas. Pancreas (2004) 0.83
Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation. J Gastrointest Surg (2007) 0.82
INI1 (BAF 47) immunohistochemistry is an essential diagnostic tool for children with hepatic tumors and low alpha fetoprotein. J Pediatr Hematol Oncol (2010) 0.82
Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia. Am J Pathol (2005) 0.82
Colonoscopic findings of symptomatic patients aged 50 to 80 years suggest that work-up of tumour suspicious symptoms hardly reduces cancer-induced mortality. Swiss Med Wkly (2005) 0.81
Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL). Eur J Cancer (2012) 0.81
Reduced hepatic glycogen stores in patients with liver cirrhosis. Liver Int (2003) 0.81
Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study. Soz Praventivmed (2004) 0.81
Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis. J Hepatol (2006) 0.80
Rapid spontaneous malignant progression of supratentorial tanycytic ependymoma with sarcomatous features - "Ependymosarcoma". Pathol Res Pract (2009) 0.80
Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. Liver (2002) 0.80
Endothelial nitric oxide synthase is not essential for the development of fibrosis and portal hypertension in bile duct ligated mice. Liver Int (2005) 0.79
The metabolic and microcirculatory impact of orthotopic liver transplantation on the obese Zucker rat. Transplantation (2003) 0.78
Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer. Am J Surg (2002) 0.78
Potential biomarkers for hepatoblastoma: results from the SIOPEL-3 study. Eur J Cancer (2011) 0.78
"Exterritorial" lymphocytic hypophysitis within an ovarian teratoma during pregnancy: a possible sentinel lesion? Pathol Res Pract (2008) 0.78
Hepatic and skeletal muscle glycogen metabolism in rats with short-term cholestasis. J Hepatol (2002) 0.78
Gene-expression analysis of single cells-nested polymerase chain reaction after laser microdissection. World J Gastroenterol (2003) 0.78
Management of hepatobiliary cystadenocarcinoma. Dig Surg (2003) 0.78
Active caspase 3 and DNA fragmentation as markers for apoptotic cell death in primary and metastatic liver tumours. Pathology (2007) 0.77
Image of the month. Gamma-Gandy bodies. Gastroenterology (2003) 0.77
Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure. Br J Clin Pharmacol (2008) 0.77
Up-regulation of p75 neurotrophin receptor (p75NTR) is associated with apoptosis in chronic pancreatitis. Dig Dis Sci (2003) 0.77
[Pharmacotherapy of hyperthyreosis--adverse drug reactions]. Ther Umsch (2011) 0.77
Differential expression of connective tissue growth factor in inflammatory bowel disease. Digestion (2004) 0.76
Bridging hyperacute liver failure by ABO-incompatible auxiliary partial orthotopic liver transplantation. Transpl Int (2007) 0.76
Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans. Eur J Pharm Sci (2010) 0.76
Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets. Eur J Pharm Sci (2008) 0.75
Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease: a case report. Eur J Gastroenterol Hepatol (2003) 0.75
Evaluation of chronic HCV infection in transplanted livers using a modified histological activity index. Ann Transplant (2011) 0.75
Necrotising vasculitis of the skin associated with an herbal medicine containing amfepramone. Eur J Clin Pharmacol (2009) 0.75
Bile duct infarction following intraarterial hepatic chemotherapy mimicking multiple liver metastasis: report of a case and review of the literature. Dig Dis Sci (2002) 0.75
Blood concentration curve of cyclosporine: impact of itraconazole in lung transplant recipients. Transplantation (2007) 0.75
Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis. Scand J Infect Dis (2009) 0.75
How much is too much? Oligosymptomatic presentation after 11.5 g of diphenhydramine. Hum Exp Toxicol (2007) 0.75
[Preferential expression of cartilage oligomeric matrix protein in degenerating acinar cells in chronic pancreatitis and in chronic pancreatitis-like lesions]. Zhonghua Wai Ke Za Zhi (2003) 0.75
Intraluminal duodenal diverticulum. Clin Gastroenterol Hepatol (2006) 0.75
Unusual evolution of posterior reversible encephalopathy syndrome (PRES) one year after liver transplantation. Liver Transpl (2005) 0.75
Persistence of impaired hepatic microcirculation after nonarterialized liver transplantation in the rat. Microcirculation (2002) 0.75